DRIO - weekly frameEarning after the close on 3/21/22...expecting short term bear move near 5.60 with possible long term bull
0%
0%
0%
0%
0%
About DarioHealth Corp
Sector
Health Technology
Industry
Biotechnology
CEO
Erez Raphael
Website
dariohealth.com
Headquarters
New York
Employees
241
Founded
2011
ISIN
US23725P2092
DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.
DarioHealth Announces Three New Contracts as Growth Continues toDRIO: DarioHealth Corp.
2021-11-11 06:40:00
DarioHealth Announces Three New Contracts as Growth Continues to Accelerate Across the Employer and Provider Markets
DRIO. Stay above 26.20, can Test 32 and run to ATH againLong DRIO, Small Cap.
Stop at 26.20 (Close Price Only)
Potentially look to add over 32
TDOC, enters Downtrend as Momentum drops below 0 level on Feb 22This indicator may be signaling that TDOC's price has further to drop, since it fell below its price logged 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options. A.I.dvisor backtested 82 similar cases where TDOC's Momentum Indicator fell below the 0 level
DRIO, MACD Histogram just turned negativeThis is a Bearish indicator signaling DRIO's price could decline from here. Traders may explore shorting the stock or put options. Tickeron's A.I.dvisor identified 51 similar cases where DRIO's MACD histogram became negative, and 42 of them led to successful outcomes. Odds of Success: 82%. Current p
Announces $28.6 Million Private PlacementDarioHealth Announces $28.6 Million Private Placement
closed a private placement transaction with accredited investors, including healthcare funds and institutions from the U.S. and Israel
pre-funded warrants to purchase 824,689 shares of common stock at an exercise price of $0.0001 per share. The
DarioHealth Corp. Breakout watch DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The
pennies to thousands new stock candidategood volume new stock no overhead supply
relative strength good
upper bands on cci and percent r
money supply increasing
candle had wick wait for good opening candle see our book on amazon for entry rules
See all ideas
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
